Cleveland BioLabs Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Cleveland BioLabs prevailing Real Value cannot be determined due to lack of data. The current price of Cleveland BioLabs is $0.0. Our model approximates the value of Cleveland BioLabs from analyzing the firm fundamentals such as return on equity of -31.86, and Current Valuation of 66.46 M as well as examining its technical indicators and probability of bankruptcy.
Cleveland BioLabs Total Value Analysis
Cleveland BioLabs is currently expected to have valuation of 66.46 M with market capitalization of 49.04 M, debt of 0, and cash on hands of 14.62 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Cleveland BioLabs fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
66.46 M | 49.04 M | 0 | 14.62 M |
Cleveland BioLabs Investor Information
About 50.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.18. Cleveland BioLabs last dividend was issued on the 29th of October 2010. The entity had 1:20 split on the 28th of January 2015. Based on the key indicators related to Cleveland BioLabs' liquidity, profitability, solvency, and operating efficiency, Cleveland BioLabs is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.Cleveland BioLabs Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cleveland BioLabs has an asset utilization ratio of 0.51 percent. This signifies that the Company is making $0.00512 for each dollar of assets. An increasing asset utilization means that Cleveland BioLabs is more efficient with each dollar of assets it utilizes for everyday operations.Cleveland BioLabs Ownership Allocation
Cleveland BioLabs holds a total of 15.47 Million outstanding shares. Cleveland BioLabs retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Cleveland BioLabs Profitability Analysis
The company reported the previous year's revenue of 106.9 K. Net Loss for the year was (2.35 M) with loss before overhead, payroll, taxes, and interest of (428.13 K).Cleveland BioLabs Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Shares Percent Shares Out | 0.19% | |
| Float Shares | 7.69M | |
| Shares Short Prior Month | 90.83k |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Cleveland Stock
If you are still planning to invest in Cleveland BioLabs check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cleveland BioLabs' history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |